cv 3988 has been researched along with Injury, Myocardial Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballagi, G; Bleese, N; Nagasawa, K; Roth, M; Sawa, Y; Schaper, J; Schaper, W | 1 |
| Kawata, H; Mayer, JE; Sawatari, K | 1 |
| Farber, NE; Gross, GJ; Jacob, HS; Maruyama, M; Vercellotti, GM | 1 |
3 other study(ies) available for cv 3988 and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Platelet-activating factor plays an important role in reperfusion injury in myocardium. Efficacy of platelet-activating factor receptor antagonist (CV-3988) as compared with leukocyte-depleted reperfusion.
Topics: Animals; Heart; Myocardial Reperfusion; Myocardial Reperfusion Injury; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Swine | 1994 |
Evidence for the role of neutrophils in reperfusion injury after cold cardioplegic ischemia in neonatal lambs.
Topics: Acetylcholine; Animals; Animals, Newborn; Cardioplegic Solutions; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Heart Arrest, Induced; Myocardial Reperfusion Injury; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Sheep; Time Factors; Vascular Resistance | 1992 |
Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs.
Topics: Animals; Chemical Phenomena; Chemistry; Diterpenes; Dogs; Electrophysiology; Ginkgolides; Lactones; Myocardial Reperfusion Injury; Phospholipid Ethers; Platelet Activating Factor; Time Factors | 1990 |